Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid - cross-over trials in Ronneby, Sweden
Gespeichert in:
| Titel: | Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid - cross-over trials in Ronneby, Sweden |
|---|---|
| Autoren: | Andersson, Axel G, Xu, Yiyi, Kärrman, Anna, Cederlund, Julia, Lindh, Christian H, Pineda, Daniela, Fletcher, Tony, Jakobsson, Kristina, Li, Ying |
| Weitere Verfasser: | Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Applied Mass Spectrometry in Environmental Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för arbets- och miljömedicin, Tillämpad masspektrometri inom miljömedicin, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Engineering, LTH, Other operations, LTH, Metalund, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Metalund, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Genetic Occupational and Environmental Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för arbets- och miljömedicin, Genetisk arbets- och miljömedicin, Originator |
| Quelle: | Environment International. 204:1-10 |
| Schlagwörter: | Medical and Health Sciences, Health Sciences, Occupational Health and Environmental Health, Medicin och hälsovetenskap, Hälsovetenskap, Arbetsmedicin och miljömedicin |
| Beschreibung: | BACKGROUND: Some per- and polyfluoroalkyl substances (PFAS) such as perfluorohexane sulfonic acid (PFHxS), perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) are very long-lived in humans, with serum half-lives of several years. In PFAS hot spots, such as Ronneby, Sweden, high exposures over time have led to markedly elevated serum PFAS levels, which may result in health risks as well as transfer to the next generation through pregnancy and breastfeeding. Bile acid sequestrants and organic anion transporter inhibitors are drug candidates for increasing PFAS elimination in humans. MATERIALS AND METHODS: This is a cross-over, clinical study in 10 individuals from Ronneby, Sweden. First, participants were given the bile acid sequestrant cholestyramine and the organic anion transporter inhibitor probenecid for 1 week each. Urinary and fecal concentrations were measured prior, during and after the administration. Then, the changes of serum PFAS concentrations during a 12-week intervention withthe bile acid sequestrant colesevelam were compared to a control period. RESULTS: The study population was mainly exposed to PFHxS (serum mean 50 ng/mL, range 5.8-170), PFOS (serum mean 46 ng/mL, range 9.2-130) and PFOA (serum mean 2.2, range 0.7-4.4). Cholestyramine intervention increased the serum adjusted fecal PFOS concentrations by 23.1 times (95 %CI: 13.6, 39.2), while probenecid was associated with 0.79 times (95 %CI 0.63, 1.0) serum-adjusted urinary PFOS concentrations, compared to no intervention. The 12-week intervention with colesevelam resulted in a mean serum PFOS decline of 38 % (95 %CI -42, -34), compared to 2 % (95 %CI -8, 5) in the control period. The decline was smaller for PFHxS and PFOA. CONCLUSIONS: Bile acid sequestrants could be used for accelerating PFAS excretion in highly PFAS exposed individuals. Studies are needed to evaluate the risks, costs and benefits of using it for this purpose. |
| Zugangs-URL: | https://doi.org/10.1016/j.envint.2025.109794 |
| Datenbank: | SwePub |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://doi.org/10.1016/j.envint.2025.109794# Name: EDS - SwePub (s4221598) Category: fullText Text: View record in SwePub – Url: https://resolver.ebscohost.com/openurl?sid=EBSCO:edsswe&genre=article&issn=18736750&ISBN=&volume=204&issue=&date=20250916&spage=1&pages=1-10&title=Environment International&atitle=Serum%2C%20urinary%20and%20fecal%20concentrations%20of%20perfluoroalkyl%20substances%20after%20interventions%20with%20cholestyramine%2Fcolesevelam%20and%20probenecid%20-%20cross-over%20trials%20in%20Ronneby%2C%20Sweden&aulast=Andersson%2C%20Axel%20G&id=DOI:10.1016/j.envint.2025.109794 Name: Full Text Finder Category: fullText Text: Full Text Finder Icon: https://imageserver.ebscohost.com/branding/images/FTF.gif MouseOverText: Full Text Finder – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Andersson%20AG Name: ISI Category: fullText Text: Nájsť tento článok vo Web of Science Icon: https://imagesrvr.epnet.com/ls/20docs.gif MouseOverText: Nájsť tento článok vo Web of Science |
|---|---|
| Header | DbId: edsswe DbLabel: SwePub An: edsswe.oai.portal.research.lu.se.publications.0956d773.5951.411f.b945.c500cd8d8b73 RelevancyScore: 1152 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1152.22827148438 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid - cross-over trials in Ronneby, Sweden – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Andersson%2C+Axel+G%22">Andersson, Axel G</searchLink><br /><searchLink fieldCode="AR" term="%22Xu%2C+Yiyi%22">Xu, Yiyi</searchLink><br /><searchLink fieldCode="AR" term="%22Kärrman%2C+Anna%22">Kärrman, Anna</searchLink><br /><searchLink fieldCode="AR" term="%22Cederlund%2C+Julia%22">Cederlund, Julia</searchLink><br /><searchLink fieldCode="AR" term="%22Lindh%2C+Christian+H%22">Lindh, Christian H</searchLink><br /><searchLink fieldCode="AR" term="%22Pineda%2C+Daniela%22">Pineda, Daniela</searchLink><br /><searchLink fieldCode="AR" term="%22Fletcher%2C+Tony%22">Fletcher, Tony</searchLink><br /><searchLink fieldCode="AR" term="%22Jakobsson%2C+Kristina%22">Jakobsson, Kristina</searchLink><br /><searchLink fieldCode="AR" term="%22Li%2C+Ying%22">Li, Ying</searchLink> – Name: Author Label: Contributors Group: Au Data: Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Applied Mass Spectrometry in Environmental Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för arbets- och miljömedicin, Tillämpad masspektrometri inom miljömedicin, Originator<br />Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator<br />Lund University, Faculty of Engineering, LTH, Other operations, LTH, Metalund, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Metalund, Originator<br />Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Genetic Occupational and Environmental Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för arbets- och miljömedicin, Genetisk arbets- och miljömedicin, Originator – Name: TitleSource Label: Source Group: Src Data: <i>Environment International</i>. 204:1-10 – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Medical+and+Health+Sciences%22">Medical and Health Sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Health+Sciences%22">Health Sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Occupational+Health+and+Environmental+Health%22">Occupational Health and Environmental Health</searchLink><br /><searchLink fieldCode="DE" term="%22Medicin+och+hälsovetenskap%22">Medicin och hälsovetenskap</searchLink><br /><searchLink fieldCode="DE" term="%22Hälsovetenskap%22">Hälsovetenskap</searchLink><br /><searchLink fieldCode="DE" term="%22Arbetsmedicin+och+miljömedicin%22">Arbetsmedicin och miljömedicin</searchLink> – Name: Abstract Label: Description Group: Ab Data: BACKGROUND: Some per- and polyfluoroalkyl substances (PFAS) such as perfluorohexane sulfonic acid (PFHxS), perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) are very long-lived in humans, with serum half-lives of several years. In PFAS hot spots, such as Ronneby, Sweden, high exposures over time have led to markedly elevated serum PFAS levels, which may result in health risks as well as transfer to the next generation through pregnancy and breastfeeding. Bile acid sequestrants and organic anion transporter inhibitors are drug candidates for increasing PFAS elimination in humans. MATERIALS AND METHODS: This is a cross-over, clinical study in 10 individuals from Ronneby, Sweden. First, participants were given the bile acid sequestrant cholestyramine and the organic anion transporter inhibitor probenecid for 1 week each. Urinary and fecal concentrations were measured prior, during and after the administration. Then, the changes of serum PFAS concentrations during a 12-week intervention withthe bile acid sequestrant colesevelam were compared to a control period. RESULTS: The study population was mainly exposed to PFHxS (serum mean 50 ng/mL, range 5.8-170), PFOS (serum mean 46 ng/mL, range 9.2-130) and PFOA (serum mean 2.2, range 0.7-4.4). Cholestyramine intervention increased the serum adjusted fecal PFOS concentrations by 23.1 times (95 %CI: 13.6, 39.2), while probenecid was associated with 0.79 times (95 %CI 0.63, 1.0) serum-adjusted urinary PFOS concentrations, compared to no intervention. The 12-week intervention with colesevelam resulted in a mean serum PFOS decline of 38 % (95 %CI -42, -34), compared to 2 % (95 %CI -8, 5) in the control period. The decline was smaller for PFHxS and PFOA. CONCLUSIONS: Bile acid sequestrants could be used for accelerating PFAS excretion in highly PFAS exposed individuals. Studies are needed to evaluate the risks, costs and benefits of using it for this purpose. – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doi.org/10.1016/j.envint.2025.109794" linkWindow="_blank">https://doi.org/10.1016/j.envint.2025.109794</link> |
| PLink | https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsswe&AN=edsswe.oai.portal.research.lu.se.publications.0956d773.5951.411f.b945.c500cd8d8b73 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.envint.2025.109794 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1 Subjects: – SubjectFull: Medical and Health Sciences Type: general – SubjectFull: Health Sciences Type: general – SubjectFull: Occupational Health and Environmental Health Type: general – SubjectFull: Medicin och hälsovetenskap Type: general – SubjectFull: Hälsovetenskap Type: general – SubjectFull: Arbetsmedicin och miljömedicin Type: general Titles: – TitleFull: Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid - cross-over trials in Ronneby, Sweden Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Andersson, Axel G – PersonEntity: Name: NameFull: Xu, Yiyi – PersonEntity: Name: NameFull: Kärrman, Anna – PersonEntity: Name: NameFull: Cederlund, Julia – PersonEntity: Name: NameFull: Lindh, Christian H – PersonEntity: Name: NameFull: Pineda, Daniela – PersonEntity: Name: NameFull: Fletcher, Tony – PersonEntity: Name: NameFull: Jakobsson, Kristina – PersonEntity: Name: NameFull: Li, Ying – PersonEntity: Name: NameFull: Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Applied Mass Spectrometry in Environmental Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för arbets- och miljömedicin, Tillämpad masspektrometri inom miljömedicin, Originator – PersonEntity: Name: NameFull: Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator – PersonEntity: Name: NameFull: Lund University, Faculty of Engineering, LTH, Other operations, LTH, Metalund, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Metalund, Originator – PersonEntity: Name: NameFull: Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Genetic Occupational and Environmental Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för arbets- och miljömedicin, Genetisk arbets- och miljömedicin, Originator IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 09 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 18736750 – Type: issn-locals Value: SWEPUB_FREE – Type: issn-locals Value: LU_SWEPUB Numbering: – Type: volume Value: 204 Titles: – TitleFull: Environment International Type: main |
| ResultId | 1 |
Full Text Finder
Nájsť tento článok vo Web of Science